WSL
CYT

Western Standard LLC’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Western Standard LLC’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-524,050
Closed -$1.36M – 38
2023
Q2 		$1.36M Buy
+524,050
New +$1.36M 1.17% 15